CD8A and colorectal cancer: For instance, METTL14 may promote CD8+ T-cell dysfunction in colorectal cancer through stabilization of Ebi3 mRNA, yet enhance T-cell activation in other contexts by facilitating PDCD1 mRNA degradation (30).